S&P 500 7,631.47 â–ŧ 54.67 (-0.71%) DOW 52,766.88 â–ŧ 419.02 (-0.79%) NASDAQ 26,099.77 â–ŧ 271.12 (-1.03%) US Markets Closed â€ĸ 02:45 AM ET

MOLN

Molecular Partners AG

Price Chart

No historical data available

Latest Quote

$4.50

-0.15 (-3.28%)
Current Price
Previous Close $4.65
Open $4.67
Day High $4.67
Day Low $4.50
Volume 1,369
Fetched: 2026-08-28T15:29:41
Stock Information
Note: Financial values converted from CHF to USD
Shares Outstanding 38.31M
Total Debt $3.76M
Cash Equivalents $83.94M
Net Income $-63.25M
Sector Healthcare
Industry Biotechnology
Market Cap $172.37M
EPS (TTM) $-1.68
Exchange NMS
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About Molecular Partners AG

Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in Phase 1 clinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin T cell engager to treat CD3 x costim x; and MP0726, a Radio-DARPin Therapy to treat ovarian cancer and other MSLNexpressing cancers. In addition, the company develops MP0621, a Switch-DARPin candidate targeting CD16a, c-KIT, and CD47 as conditioning for hematopoietic stem cell transplantation; and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics and an additional six targeted alpha therapeutics candidates and Eckert & Ziegler SE to develop Radio-DARPin therapeutics. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.

📰 Latest News
No news articles available at the moment. Check back later for updates on MOLN.
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Total Revenue $0 $6,219,497 $8,807,409 $237,211,876
Operating Revenue $0 $6,219,497 $8,807,409 $237,211,876
Expenses
Interest Expense $22,525 $31,285 $42,548 $757,102
Total Expenses $69,373,048 $82,826,935 $85,278,443 $91,281,446
Other Income Expense $-9,638,344 $4,792,892 $-6,389,689 $897,259
Net Non Operating Interest Income Expense $1,863,346 $4,187,211 $5,293,455 $654,486
Total Other Finance Cost $18,771 $16,268 $18,771 $17,520
Interest Expense Non Operating $22,525 $31,285 $42,548 $757,102
Operating Expense $69,373,048 $82,826,935 $85,278,443 $91,281,446
General And Administrative Expense $18,609,687 $21,479,165 $23,770,493 $27,308,223
Other Operating Expenses - - - $-55,062
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-77,150,548 $-67,629,837 $-77,567,267 $147,482,175
Net Interest Income $1,863,346 $4,187,211 $5,293,455 $654,486
Interest Income $1,904,643 $4,234,764 $5,354,774 $1,429,108
Normalized Income $-68,331,464 $-72,015,334 $-72,410,788 $146,758,984
Net Income From Continuing And Discontinued Operation $-77,150,548 $-67,629,837 $-77,567,267 $147,482,175
Total Operating Income As Reported $-72,736,833 $-76,607,437 $-76,471,034 $145,930,429
Net Income Common Stockholders $-77,150,548 $-67,629,837 $-77,567,267 $147,482,175
Net Income $-77,150,548 $-67,629,837 $-77,567,267 $147,482,175
Net Income Including Noncontrolling Interests $-77,150,548 $-67,629,837 $-77,567,267 $147,482,175
Net Income Continuous Operations $-77,150,548 $-67,629,837 $-77,567,267 $147,482,175
Pretax Income $-77,148,046 $-67,627,334 $-77,567,267 $147,482,175
Special Income Charges $-3,365,036 $0 $0 -
Interest Income Non Operating $1,904,643 $4,234,764 $5,354,774 $1,429,108
Operating Income $-69,373,048 $-76,607,437 $-76,471,034 $145,930,429
Depreciation Amortization Depletion Income Statement $464,272 $524,340 $459,267 $520,586
Depreciation And Amortization In Income Statement $464,272 $524,340 $459,267 $520,586
Per Share
Diluted EPS $-2.06 $-1.99 $-2.37 $4.43
Basic EPS $-2.06 $-1.99 $-2.37 $4.54
Other
Tax Effect Of Unusual Items $-819,259 $407,396 $-1,233,210 $174,068
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-64,804,158 $-69,424,356 $-68,106,624 $150,330,380
Total Unusual Items $-9,638,344 $4,792,892 $-6,389,689 $897,259
Total Unusual Items Excluding Goodwill $-9,638,344 $4,792,892 $-6,389,689 $897,259
Reconciled Depreciation $2,683,019 $2,964,585 $3,028,407 $2,988,362
EBITDA (Bullshit earnings) $-74,442,502 $-64,631,464 $-74,496,312 $151,227,639
EBIT $-77,125,520 $-67,596,049 $-77,524,719 $148,239,277
Diluted Average Shares $46,641,575 $42,588,594 $41,009,469 $41,628,793
Basic Average Shares $46,641,575 $42,588,594 $41,009,469 $40,633,161
Diluted NI Availto Com Stockholders $-77,150,548 $-67,629,837 $-77,567,267 $147,482,175
Tax Provision $2,503 $2,503 $0 $0
Restructuring And Mergern Acquisition $3,365,036 $0 $0 -
Gain On Sale Of Security $-6,273,308 $4,792,892 $-6,389,689 $897,259
Research And Development $50,299,089 $60,823,430 $61,048,683 $63,507,700
Selling General And Administration $18,609,687 $21,479,165 $23,770,493 $27,308,223
Other Gand A $6,362,158 $7,762,483 $9,204,105 $12,556,627
Salaries And Wages $12,247,529 $13,716,682 $14,566,388 $14,751,596
Fetched: 2026-08-21
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $100,528,099 $177,184,342 $220,519,346 $293,949,459
Total Assets $127,777,506 $198,383,192 $248,219,260 $328,191,733
Total Non Current Assets $6,546,115 $5,314,729 $7,374,547 $9,393,068
Goodwill And Other Intangible Assets $2,503 $61,319 $265,298 $339,132
Other Intangible Assets $2,503 $61,319 $265,298 $339,132
Current Assets $121,231,392 $193,068,462 $240,844,713 $318,798,665
Other Current Assets $-1,251 - - -
Prepaid Assets $2,395,195 $2,814,416 $3,111,000 $4,893,005
Receivables $2,383,932 $3,244,901 $3,859,342 $2,124,891
Other Receivables $190,214 $441,747 $1,497,935 $943,562
Taxes Receivable $1,877,112 $2,445,251 $1,992,241 $529,346
Accounts Receivable $316,606 $357,903 $369,165 $651,984
Cash Cash Equivalents And Short Term Investments $116,453,516 $187,009,145 $233,874,371 $311,780,770
Cash And Cash Equivalents $103,432,617 $79,932,428 $84,231,014 $110,056,319
Cash Financial $103,432,617 $79,932,428 $84,231,014 $110,056,319
Other Non Current Assets - - - -
Debt
Total Debt $4,560,130 $3,058,441 $4,570,142 $6,069,328
Long Term Debt And Capital Lease Obligation $3,050,932 $1,535,477 $3,058,441 $4,570,142
Current Debt And Capital Lease Obligation $1,509,198 $1,522,963 $1,511,701 $1,499,187
Liabilities
Total Liabilities Net Minority Interest $27,246,904 $21,137,531 $27,434,615 $33,903,143
Total Non Current Liabilities Net Minority Interest $13,447,629 $7,641,097 $9,394,319 $12,315,105
Other Non Current Liabilities $1,251 - - -
Tradeand Other Payables Non Current $200,225 $0 - -
Current Liabilities $13,799,275 $13,496,434 $18,040,296 $21,588,038
Other Current Liabilities $1,251 - - -
Payables And Accrued Expenses $12,288,826 $11,973,471 $11,106,245 $12,068,578
Payables $2,209,986 $2,326,367 $1,661,870 $2,681,767
Other Payable $1,037,417 $1,476,661 $1,148,792 $1,434,113
Accounts Payable $1,172,569 $849,706 $513,077 $1,247,654
Current Deferred Liabilities - $0 $5,422,350 $8,020,273
Non Current Deferred Liabilities - - $0 $4,551,371
Total Tax Payable - - - $0
Equity
Common Stock Equity $100,530,602 $177,245,661 $220,784,644 $294,288,590
Total Equity Gross Minority Interest $100,530,602 $177,245,661 $220,784,644 $294,288,590
Stockholders Equity $100,530,602 $177,245,661 $220,784,644 $294,288,590
Retained Earnings $-390,130,167 $-308,213,006 $-239,963,722 $-159,904,901
Gains Losses Not Affecting Retained Earnings - - - $-1,227,631
Other Equity Adjustments - - - $-1,227,631
Other
Treasury Shares Number $3,707,888 $4,379,928 $4,379,928 -
Ordinary Shares Number $46,817,257 $46,130,768 $41,114,127 $45,106,630
Share Issued $50,525,145 $50,510,696 $45,494,054 $45,106,630
Tangible Book Value $100,528,099 $177,184,342 $220,519,346 $293,949,459
Invested Capital $100,530,602 $177,245,661 $220,784,644 $294,288,590
Working Capital $107,432,117 $179,572,028 $222,804,417 $297,210,628
Capital Lease Obligations $4,560,130 $3,058,441 $4,570,142 $6,069,328
Total Capitalization $100,530,602 $177,245,661 $220,784,644 $294,288,590
Treasury Stock $1,412,840 $1,227,631 $1,227,631 $1,227,631
Additional Paid In Capital $487,021,675 $481,635,616 $457,427,130 $450,911,049
Capital Stock $5,051,934 $5,050,682 $4,548,868 $4,510,074
Common Stock $5,051,934 $5,050,682 $4,548,868 $4,510,074
Employee Benefits $10,195,220 $6,105,619 $6,335,878 $3,193,593
Long Term Capital Lease Obligation $3,050,932 $1,535,477 $3,058,441 $4,570,142
Current Capital Lease Obligation $1,509,198 $1,522,963 $1,511,701 $1,499,187
Current Accrued Expenses $10,078,839 $9,647,104 $9,444,375 $9,386,811
Net PPE $6,543,612 $5,253,410 $7,109,248 $9,053,936
Accumulated Depreciation $-24,870,481 $-22,856,965 $-20,450,508 $-18,391,942
Gross PPE $31,414,093 $28,110,376 $27,559,756 $27,445,878
Leases $792,141 $792,141 $792,141 $780,879
Other Properties $28,321,864 $24,550,120 $24,222,251 $12,071,081
Machinery Furniture Equipment $2,300,088 $2,768,114 $2,545,364 $14,593,919
Properties $0 $0 $0 $0
Other Short Term Investments $13,020,899 $107,076,717 $149,643,357 $201,724,451
Current Deferred Revenue - $0 $5,422,350 $8,020,273
Non Current Deferred Revenue - - $0 $4,551,371
Fetched: 2026-08-21
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-65,036,920 $-75,048,183 $-74,850,461 $146,601,184
Operating Activities
Operating Cash Flow $-64,143,415 $-74,143,415 $-73,839,323 $148,374,429
Cash Flow From Continuing Operating Activities $-64,140,912 $-74,143,415 $-73,839,323 $148,374,429
Operating Gains Losses $-683,269 $-838,443 $669,503 $1,435,365
Investing Activities
Capital Expenditure $-893,505 $-904,768 $-1,011,138 $-1,773,245
Investing Cash Flow $90,788,392 $50,664,500 $55,859,094 $-126,543,618
Cash Flow From Continuing Investing Activities $90,788,392 $50,664,500 $55,859,094 $-126,543,618
Financing Activities
Issuance Of Capital Stock $0 $21,701,916 $0 $0
Financing Cash Flow $-1,437,868 $18,061,570 $-1,460,393 $-1,964,710
Cash Flow From Continuing Financing Activities $-1,437,868 $18,061,570 $-1,460,393 $-1,964,710
Net Common Stock Issuance $0 $21,701,916 $0 $-789,638
Common Stock Issuance $0 $21,701,916 $0 $0
Repurchase Of Capital Stock - $0 $0 $-789,638
Net Other Financing Charges - $-2,178,701 - -
Other
Repayment Of Debt $-1,516,706 $-1,511,701 $-1,499,187 $-1,487,924
End Cash Position $103,432,617 $79,932,428 $84,231,014 $110,056,319
Beginning Cash Position $79,932,428 $84,231,014 $110,056,319 $89,867,356
Effect Of Exchange Rate Changes $-1,706,920 $1,118,759 $-6,384,683 $322,863
Changes In Cash $25,207,109 $-5,417,345 $-19,440,622 $19,866,100
Proceeds From Stock Option Exercised $78,839 $50,056 $38,794 $312,852
Net Issuance Payments Of Debt $-1,516,706 $-1,511,701 $-1,499,187 $-1,487,924
Net Long Term Debt Issuance $-1,516,706 $-1,511,701 $-1,499,187 $-1,487,924
Long Term Debt Payments $-1,516,706 $-1,511,701 $-1,499,187 $-1,487,924
Interest Received Cfi $2,161,181 $5,304,718 $4,789,138 $618,196
Net Investment Purchase And Sale $89,520,716 $46,264,550 $52,081,094 $-125,388,569
Sale Of Investment $172,461,528 $346,658,759 $399,753,494 $249,304,230
Purchase Of Investment $-82,940,813 $-300,394,209 $-347,672,400 $-374,692,799
Net Intangibles Purchase And Sale $0 $-22,525 $-291,578 $-300,338
Purchase Of Intangibles $0 $-22,525 $-291,578 $-300,338
Net PPE Purchase And Sale $-893,505 $-882,243 $-719,560 $-1,472,907
Purchase Of PPE $-893,505 $-882,243 $-719,560 $-1,472,907
Interest Paid Cfo $-22,525 $-32,537 $-42,548 $-808,410
Change In Working Capital $1,514,204 $-4,751,596 $-7,520,961 $-7,520,961
Change In Other Working Capital $-22,525 $-5,471,155 $-7,175,573 $-31,645,603
Change In Other Current Assets $419,222 $296,584 $1,782,005 $2,236,266
Change In Payables And Accrued Expense $510,574 $857,214 $-959,830 $-9,727,194
Change In Accrued Expense $429,233 $201,477 $56,313 $-3,045,927
Change In Payable $81,342 $655,738 $-1,016,143 $-6,681,267
Change In Receivables $606,933 $-434,239 $-1,167,564 $31,615,569
Other Non Cash Items $3,983,231 $-8,995,120 $1,077,462 $-1,569,266
Stock Based Compensation $5,529,972 $5,137,029 $6,516,081 $6,367,163
Deferred Tax $2,503 $2,503 $0 $0
Deferred Income Tax $2,503 $2,503 $0 $0
Depreciation Amortization Depletion $2,683,019 $2,964,585 $3,028,407 $2,988,362
Depreciation And Amortization $2,683,019 $2,964,585 $3,028,407 $2,988,362
Amortization Cash Flow $57,565 $226,505 $365,411 -
Amortization Of Intangibles $57,565 $226,505 $365,411 -
Depreciation $2,624,202 $2,738,080 $2,662,996 -
Pension And Employee Benefit Expense $-683,269 $-838,443 $669,503 $1,435,365
Net Income From Continuing Operations $-77,150,548 $-67,629,837 $-77,567,267 $147,482,175
Common Stock Payments - $0 $0 $-789,638
Taxes Refund Paid - $0 $0 $0
Change In Account Payable - $655,738 $-1,016,143 $-6,681,267
Change In Prepaid Assets - - - -
Fetched: 2026-08-21